TC
CVS icon

Trilogy Capital’s CVS Health CVS Stock Holding History

Trilogy Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,639
Closed -$287K – 301
2023
Q4 		$287K Sell
3,639
-1,768
-33% -$126K 0.02% 215
2023
Q3 		$377K Sell
5,407
-462
-8% -$32.7K 0.03% 182
2023
Q2 		$440K Buy
5,869
+1,094
+23% +$77.8K 0.03% 182
2023
Q1 		$355K Buy
4,775
+869
+22% +$72.9K 0.03% 182
2022
Q4 		$364K Buy
3,906
+536
+16% +$51.7K 0.03% 176
2022
Q3 		$321K Buy
3,370
+586
+21% +$58K 0.03% 145
2022
Q2 		$258K Buy
2,784
+529
+23% +$51.6K 0.02% 139
2022
Q1 		$228K Buy
+2,255
New +$237K 0.02% 161
2020
Q1 		– Sell
-3,176
Closed -$234K – 112
2019
Q4 		$234K Buy
+3,176
New +$223K 0.02% 108
2018
Q4 		– Sell
-33
Closed -$3K – 223
2018
Q3 		$3K Hold
33
– – ﹤0.01% 449
2018
Q2 		$2K Hold
33
– – ﹤0.01% 453
2018
Q1 		$2K Sell
33
-6,167
-99% -$442K ﹤0.01% 379
2017
Q4 		$449K Buy
+6,200
New +$451K 0.07% 86

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trilogy Capital's CVS Position: Q1 2024 in Review

Trilogy Capital sold out of CVS Health (CVS) in Q1 2024, closing a stake of 3,639 shares — an estimated $287K sold.

Trilogy Capital first reported a position in CVS in Q4 2017 and held it in 13 quarters. The position peaked at $449K in Q4 2017. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Trilogy Capital reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Trilogy Capital sold 3,639 CVS Health shares in Q1 2024, an estimated $287K.
  • Trilogy Capital first reported a position in CVS Health in Q4 2017 and held it in 13 quarters.
  • Trilogy Capital's CVS Health position peaked at $449K in Q4 2017.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.